ADM, Brightseed partnership aims at decoding microbiome, bioactives
The project will examine how various bioactives could impact human health.
ADM (a supplier of nutrition solutions for food, beverage, and health and wellness brands) and Brightseed (a bioactives company and a World Economic Forum Global Innovator) have announced a global joint partnership to develop evidence-based functional synbiotic products that target microbiome optimization with an undisclosed investment. ADM is leveraging Brightseed’s artificial intelligence (AI) platform, Forager, to decipher the molecular interactions between dietary plants and gut microbes and their potential impact on human health.
“We know from our recent research into global consumer trends that macro forces, including the lingering pandemic, have coincided with an increased demand for natural and plant-based solutions that target immune function, metabolic health, and mental well-being,” says Mark Lotsch, ADM’s president of global health and wellness. “We are thrilled to partner with Brightseed to lead in state-of-the-art discovery on the microbiome, and to bring forward science-backed solutions that empower consumers toward proactive and individualized health.”